Skip to main content
OpenTrials

Clinical trial condition

Ovarian Cancer

Explore clinical trials studying Ovarian Cancer. Study availability and eligibility vary by location and protocol.

1,442 public trials 325 recruiting studies
Refine in advanced search Browse all conditions

Ovarian Cancer trial results

Active, Not Recruiting

A Collaborative Trial of Niraparib to Evaluate Patients With Ovarian Cancer in the Expanded Access Program in Latin America

NCT05857397

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • COIP - Centro Oncologico Integral Pampeano Santa Rosa, La Pampa Province, Argentina
  • Sanatorio de la Mujer Rosario, Santa Fe Province, Argentina
  • Fundacion Medica de Rio Negro y Neuquen Neuquén, Argentina
  • CINPAM - Centro Integrado de Pesquisa da Amazônia Manaus, Amazonas, Brazil
View all 16 locations
View Trial Details
Active, Not Recruiting

A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies

NCT05032040

Conditions
Adenocarcinoma, Adenocarcinoma, Clear Cell, Adnexal Diseases, +34 more
Locations
  • Arizona Oncology Associates, PC - NAHOA Prescott, Arizona, United States
  • UCSD Moores Cancer Center La Jolla, California, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • UCLA Medical Center Los Angeles, California, United States
View all 17 locations
View Trial Details
Active, Not Recruiting

A Study of Avutometinib (VS-6766) v. Avutometinib (VS-6766) + Defactinib in Recurrent Low-Grade Serous Ovarian Cancer With and Without a KRAS Mutation

NCT04625270

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
Locations
  • Arizona Oncology Associates PC HAL Scottsdale, Arizona, United States
  • Sansum Clinic Santa Barbara, California, United States
  • Yale School of Medicine New Haven, Connecticut, United States
  • Advent Health Orlando, Florida, United States
View all 47 locations
View Trial Details
Active, Not Recruiting

A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants with Advanced Unresectable or Metastatic Solid Tumors

NCT05572684

Conditions
Adnexal Diseases, Advanced or Metastatic Solid Tumors, Cervical Cancer, +52 more
Locations
  • Arizona Oncology Associates Tucson, Arizona, United States
  • Rocky Mountain Cancer Centers Aurora, Colorado, United States
  • St. Elizabeth Edgewood Hospital Edgewood, Kentucky, United States
  • Ochsner Cancer Institute New Orleans, Louisiana, United States
View all 17 locations
View Trial Details

Related conditions